Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling

被引:104
作者
Yarbrough, WM
Mukherjee, R
Escobar, GP
Mingoia, JT
Sample, JA
Hendrick, JW
Dowdy, KB
McLean, JE
Lowry, AS
O'Neill, TP
Spinale, FG
机构
[1] Med Univ S Carolina, Div Cardiothorac Surg, Charleston, SC 29425 USA
[2] Procter & Gamble Pharmaceut, Mason, OH USA
关键词
myocardial infarction; metalloproteinases; inhibitors;
D O I
10.1161/01.CIR.0000091087.78630.79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-A cause-and-effect relationship exists between matrix metalloproteinase (MMP) induction and left ventricular (LV) remodeling after myocardial infarction (MI). Whether broad-spectrum MMP inhibition is necessary and the timing at which MMP inhibition should be instituted after MI remain unclear. This study examined the effects of MMP-1 and MMP-7-sparing inhibition (sMMPi) on regional and global LV remodeling when instituted before or after MI. Methods and Results-Pigs instrumented with coronary snares and radiopaque markers within the area at risk were randomized to MI only (n=11) or sMMPi (PGE-530742, 10 mg/kg PO TID) begun 3 days before MI (n=11) or 3 days after MI (n=10). Eleven weight-matched noninstrumented pigs served as reference controls. At 10 days after MI, infarct size was similar between groups (47+/-3% of the area at risk). Marker area increased from baseline in the MI-only group (10+/-3%, P<0.05) but was unchanged with sMMPi. LV end-diastolic volume increased in the MI-only group (82±3 mL) compared with controls (56±3 mL, P<0.05) but was attenuated with pre-MI and post-MI sMMPi (69+/-3 and 69+/-4 mL, respectively, P<0.05). Collagen content increased in the infarct zone of the MI-only group (34±5%) compared with control (2±1%, P<0.05) but was reduced with pre-MI and post-MI sMMPi (24+/-1% and 23+/-2%, P<0.05). Collagen content increased in the border zone (12±2%) and decreased in the remote zone (3±1%) of the pre-MI sMMPi group compared with post-MI sMMPi values (7±1% and 5±1%, P<0.05). Conclusions-Inhibition of MMP-1 and -7 is not required to favorably influence LV remodeling after MI. Moreover, a temporal difference exists with respect to the timing of sMMPi and regional and global myocardial remodeling patterns after MI.
引用
收藏
页码:1753 / 1759
页数:7
相关论文
共 27 条
[1]   Timeline - Matrix metalloproteinases: a tail of a frog that became a prince [J].
Brinckerhoff, CE ;
Matrisian, LM .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (03) :207-214
[2]   LEFT-VENTRICULAR FUNCTION IN EXPERIMENTAL VOLUME OVERLOAD HYPERTROPHY [J].
CARABELLO, BA ;
NAKANO, K ;
CORIN, W ;
BIEDERMAN, R ;
SPANN, JF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (04) :H974-H981
[3]   The infarcted myocardium: Simply dead tissue, or a lively target for therapeutic interventions [J].
Cleutjens, JPM ;
Blankesteijn, WM ;
Daemen, MJAP ;
Smits, JFM .
CARDIOVASCULAR RESEARCH, 1999, 44 (02) :232-241
[4]   Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure? [J].
Creemers, EEJM ;
Cleutjens, JPM ;
Smits, JFM ;
Daemen, MJAP .
CIRCULATION RESEARCH, 2001, 89 (03) :201-210
[5]   Preclinical and clinical studies of MMP inhibitors in cancer [J].
Drummond, AH ;
Beckett, P ;
Brown, PD ;
Bone, EA ;
Davidson, AH ;
Galloway, WA ;
Gearing, AJH ;
Huxley, P ;
Laber, D ;
McCourt, M ;
Whittaker, M ;
Wood, LM ;
Wright, A .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :228-235
[6]   Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction [J].
Ducharme, A ;
Frantz, S ;
Aikawa, M ;
Rabkin, E ;
Lindsey, M ;
Rohde, LE ;
Schoen, FJ ;
Kelly, RA ;
Werb, Z ;
Libby, P ;
Lee, RT .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) :55-62
[7]   Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs [J].
Etoh, T ;
Joffs, C ;
Deschamps, AM ;
Davis, J ;
Dowdy, K ;
Hendrick, J ;
Baicu, S ;
Mukherjee, R ;
Manhaini, M ;
Spinale, FG .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (03) :H987-H994
[8]  
Gerdes A M, 1998, J Card Fail, V4, P343, DOI 10.1016/S1071-9164(98)90240-8
[9]  
Gunasinghe Sajeevani K., 2001, Current Drug Targets - Cardiovascular and Haematological Disorders, V1, P75, DOI 10.2174/1568006013337953
[10]   Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure [J].
Heymans, S ;
Luttun, A ;
Nuyens, D ;
Theilmeier, G ;
Creemers, E ;
Moons, L ;
Dyspersin, GD ;
Cleutjens, JPM ;
Shipley, M ;
Angellilo, A ;
Levi, M ;
Nübe, O ;
Baker, A ;
Keshet, E ;
Lupu, F ;
Herbert, JM ;
Smits, JFM ;
Shapiro, SD ;
Baes, M ;
Borgers, M ;
Collen, D ;
Daemen, MJAP ;
Carmeliet, P .
NATURE MEDICINE, 1999, 5 (10) :1135-1142